{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:49:29Z","timestamp":1790196569766,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011151","name":"American Academy of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ophtha.2024.02.019","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T22:12:54Z","timestamp":1713651174000},"page":"1107-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies"],"prefix":"10.1016","volume":"131","author":[{"given":"Justine R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Flaxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen G.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriji","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2024.02.019_bib1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ophtha.2014.07.007","article-title":"Long-term clinical outcome and causes of vision loss in patients with uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib4","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ophtha.2013.01.069","article-title":"Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema","volume":"120","author":"Kempen","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09273948.2019.1576910","article-title":"Epidemiology of macular edema in uveitis","volume":"27","author":"Accorinti","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2024.02.019_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2013.09.023","article-title":"Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema","volume":"121","author":"Levin","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib9","first-page":"83","article-title":"Periocular corticosteroid injections: uses and abuses","volume":"55","author":"O\u2019Connor","year":"1976","journal-title":"Eye Ear Nose Throat Mon"},{"key":"10.1016\/j.ophtha.2024.02.019_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib12","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib13","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/IAE.0000000000002279","article-title":"Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, phase 2 study (DOGWOOD)","volume":"39","author":"Yeh","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2024.02.019_bib14","series-title":"The Oxford 2011 levels of evidence","year":"2014"},{"key":"10.1016\/j.ophtha.2024.02.019_bib15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","article-title":"Novel method for analyzing Snellen visual acuity measurements","volume":"30","author":"Gregori","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2024.02.019_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00417-006-0378-3","article-title":"Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis","volume":"245","author":"Venkatesh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/09273940802209153","article-title":"Comparison of the efficacy and safety of different methods of posterior subtenon injection","volume":"16","author":"Venkatesh","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2024.02.019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000458157","article-title":"Quantitative analysis of uveitis macular edema in multiple sclerosis patients receiving deep posterior sub-Tenon triamcinolone acetonide injection","volume":"58","author":"Jovanovi\u0107","year":"2017","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ophtha.2024.02.019_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bjophthalmol-2015-308008","article-title":"Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon\u2019s triamcinolone acetonide for uveitic cystoid macular oedema","volume":"101","author":"Sreekantam","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib20","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib21","first-page":"1139","article-title":"Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)","volume":"106","author":"Khurana","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2021.10.024","article-title":"Optical coherence tomography anatomic and temporal biomarkers in uveitic macular edema","volume":"237","author":"Ciulla","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib23","first-page":"136","article-title":"Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema","volume":"9","author":"Rahimi","year":"2012","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/jop.2009.0093","article-title":"Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study","volume":"26","author":"Soheilian","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2024.02.019_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/09273948.2015.1025982","article-title":"Intravitreal triamcinolone injection for uveitic macular edema: a randomized clinical study","volume":"23","author":"Shin","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2024.02.019_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/0301-4738.159870","article-title":"Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(R) in patients with uveitic cystoid macular edema","volume":"63","author":"Bansal","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ophtha.2017.12.038","article-title":"Dexamethasone inserts in noninfectious uveitis: a single-center experience","volume":"125","author":"Pohlmann","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-014-0027-6","article-title":"Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis: 3-year results of a randomized clinical trial in a predominantly Asian population","volume":"4","author":"Sangwan","year":"2015","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ophtha.2024.02.019_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ophtha.2018.10.033","article-title":"Effect of an injectable fluocinolone acetonide insert on recurrence rates in chronic noninfectious uveitis affecting the posterior segment: twelve-month results","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ophtha.2020.08.035","article-title":"Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study results","volume":"128","author":"Tomkins-Netzer","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment Trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib34","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.ophtha.2015.06.042","volume":"122","author":"Kempen","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib35","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2015.07.036","article-title":"Outcome of treatment of uveitic macular edema: the Multicenter Uveitis Steroid Treatment Trial 2-year results","volume":"122","author":"Tomkins-Netzer","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2009.11.027","article-title":"Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis","volume":"117","author":"Pavesio","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.02.019_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics","volume":"149","author":"Kempen","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.02.019_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:12:10Z","timestamp":1728533530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642024001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0161642024001581"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.02.019","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}